- Research scientist, Angion Biomedica, 2020-2022
Education
- State University of New York at Stony Brook, Ph.D., 2018, organic chemistry
- Nankai University, B.S., 2013, chemistry
Bar Admissions
- U.S. Patent and Trademark Office
Languages
- Mandarin
- Co-speaker, “Design, Synthesis and Biological Evaluation of Novel Tumor-Targeted Drug Delivery Systems for a Third Generation Taxoid, Combretastatin, and Their Combination,” Abstracts of Papers, 251st ACS National Meeting & Exposition, Philadelphia, PA, 2016.
- Co-speaker, “Computational Structural-Based Design and Structure and Activity Study of Fluorinated Combretastatin Analogues,” Abstracts of Papers, 253rd ACS National Meeting & Exposition, San
Francisco, CA, 2017.
- Co-author, “Computational Design and Synthesis of Novel Fluoro-Analogs of Combretastatin A-4 and A-1,” Journal of Fluorine Chemistry, 2017.




